Background Mitroflow pericardial valves (model A12) are used for aortic valve replacement
with favorable hemodynamic results, and are ideal for patients with a small aortic annulus as …

Abstract Background Valve-in-valve (ViV) transcatheter aortic valve replacement is indicated
in patients undergoing repeat intervention for degenerative aortic valve bioprostheses …

Background Structural valve deterioration (SVD) is a known limitation of bioprosthetic
valves. Recent reports have suggested a concerning rate of early SVD in patients receiving …

Background Surgical aortic bioprosthetic valves deteriorate 10 to 20 years after operation.
Valve‐in‐valve implantation with first generation transcatheter aortic valve implantation …

Objectives Bioprostheses with pericardial leaflets mounted externally on the stent pose a
high risk for valve‐in‐valve (ViV) procedures. This study analyzed the efficacy and safety of …

Purpose In the present report we describe our clinical experience using specific image-
based decision making and anatomic considerations for transcatheter valve-in-valve (ViV) …

OBJECTIVES This study aims to analyse the risks associated with valve-in-valve procedures
for treating structural valve deterioration in Mitroflow bioprostheses, as well as to determine …

BACKGROUND: An 83-year-old woman was referred to our dedicated out-patient clinic for
evaluation of the feasibility of transcatheter mitral valve-in-valve implantation. She was …

Avoiding coronary artery obstruction following transcatheter aortic valve-in-valve insertion for
Mitroflow aortic valve dysfunction. - Abstract - Europe PMC Sign in | Create an account …